A previous preclinical study of LUM in mice bearing breast cancer tumors resulted in a maximum tumor concentration of 16.36 nmol/g tumor at an intravenous dose of 30 mg/kg free LUM18, which is comparable to the human dose of 70 mg/m223. This evidence concerns the gene LUM and neoplasm.